The festive and extremely well-attended event included trainees, faculty, as well as Dr. Susana Morales, Vice Chair, Office of Diversity, and many other members of diversity leadership.
Dr. Crow provided an analysis on new findings involving the overproduction of type 1 interferon in lupus. The research has yielded data on one of the mechanisms that might explain why interferon is being made in excess in lupus.
The editorial notes that there is a challenge in designing clinical trials for lupus in terms of selection of outcomes instruments and suggests a remedy.
